Itraconazole-associated adverse events in fungal infections: a study of a large real-world sample based on the FAERS database (2019–2024)

Alice in wonderland syndrome: Down the rabbit hole of VigiBase®

Comparative Accuracy, Stability, and Correctability of Large Language Models in Otolaryngology and Pharmacovigilance

Anesthesia Drug Shortages: Crisis Management in the Operating Room

Adverse drug reactions monitoring in the third trimester pregnant women from rural population of central India visiting tertiary care hospital: A cross- sectional pharmacovigilance study.

A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Differential Analysis of Neonatal Adverse Drug Events from Intrauterine and Extrauterine Exposure: Insights into Administration Routes Using the FAERS Database

Physiological and metabolomic insights into the toxicity mechanisms of antipsychotic drug chlorpromazine hydrochloride on Microcystis aeruginosa

Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend

Adverse Drug Reaction to Linezolid in Drug-Resistant Tuberculosis: A Systematic Review

Real-World Data on Severe Cutaneous Adverse Reactions to Drugs

Pharmacovigilance practices for new drugs in Thailand: A situation analysis in tertiary and university hospitals

Unmeasured Corticosteroid Burden May Mask Safety Signals in Herbal Medicine Users: A Call for Dosage Adjustment

Pharmacomicrobiomics in Hepatobiliary Disease: The Role of the Gut Microbiota in Drug Disposition and Safety

Improvements of an Oral Anti-cancer Drug Safety Management Program for Patients with Cancer

THE DARK PRESCRIPTION: INSIDE THE INFRASTRUCTURE OF ILLEGAL ONLINE PHARMACIES

Artificial intelligence in medication management and drug dosing in critical care

Microbiotoxicity: an under-recognised player in drug efficacy, toxicity, and health outcomes

Medication Errors Disproportionately Affect Vulnerable Populations

Machine learning prediction of pediatric adverse drug reactions using consensus-derived scarce data

La AEMPS informa sobre la retirada del mercado de un lote de Blokium-Diu 100 mg/25 mg comprimidos por un defecto de calidad

A Hybrid Pharmacovigilance Method for National-Scale Comorbidity Discovery: Association Rules with FDA-Approved PRR/Chi-square and EBGM Validation.

A real-world pharmacovigilance study of modafinil events in the FDA Adverse Event Reporting System (FAERS)

Neurological drugs induced congenital anomalies: A pharmacovigilance analysis of neonatal reports in the FDA adverse event reporting system (FAERS)

Complex chronic adverse events following immunization: a systemic critique and reform proposal for vaccine pharmacovigilance

Intelligent Counterfeit Detection Through Hybrid Pattern Mining and Blockchain Traceability: A Drug Distribution Case Study

Revisiting the Anti-Drug Antibody Assay Drug Tolerance of a Commercial Biological Product

Disproportionality analysis of Satralizumab in FDA Adverse Event Reporting System and Japanese Adverse Drug Event Report: a pharmacovigilance study

Does Enforcement of Drug Regimen Reviews Improve Medication Safety and Management in Nursing Homes? An Analysis of the CMS Drug Regimen Review Policy

Unlicensed medical practice as a public health risk: Implications for Korean Medicine

Systematic review and meta-analysis of chemotherapy-induced adverse drug reactions among children with cancer in Africa

Resistencia a antibióticos: un problema muy preocupante, especialmente en edades pediátricas

Methadone, Buprenorphine May Lower Opioid Overdose Risk

The effect of a police crackdown on online drug sales: on the importance of targeting vendors’ reputation?

Liver Toxicity: Structural Knowledge May Help Avoiding Rare Drug Adverse Events

Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend

Boletín sobre Seguridad de Medicamentos de Uso Humano. Octubre de 2025

Orchestrating generative AI in pharmacovigilance: predicting and preempting the unpredictable

Del paciente al ecosistema: la farmacovigilancia en el contexto de la farmacoecología

Antidepressant medications: a comprehensive review of efficacy, safety, and future directions

Transformer-based models for ADR detection: cross-drug validation and benchmarking against large language models

Analysis of Drug Product Dispensing Error Characteristics, Construction and Evaluation of a Risk Warning Model in Outpatient Pharmacy: A Retrospective Study in China

Proton Pump Inhibitors Under Scrutiny: How Real Is the Risk?

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Healthcare regulator suggests simple winter wellness choices to keep you safe this cough and cold season

Identification of the consequences of the proliferation of counterfeit sports supplements market

Counterfeit Medicine Knowledge and Practices among Dental and Pharmacy Faculty–A South Indian Questionnaire Study

Medication Errors Review and Prevention Strategies

Intervenidos 70.000 medicamentos en 20 maletas facturadas en el aeropuerto Tenerife Norte

Fedratinib in chronic kidney disease: antifibrotic potential and renal safety signals from integrated network toxicology and pharmacovigilance

Therapeutic Ineffectiveness of Calcitonin Gene-Related Peptide Antagonists: A Real-World Pharmacovigilance Analysis

Artificial intelligence in oncology drug development and management: a precision medicine perspective

Differential risk of adverse drug reactions with baricitinib across age groups: integrating real-world pharmacovigilance and genetic causal inference

Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review

Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System

Disproportionality analysis of Atrial Fibrillation associated with Direct Oral Anticoagulants: A Pharmacovigilance study using the Food and Drug Administration Adverse Event Reporting System database

Pharmacovigilance Investigation of Tyrosine Kinase Inhibitors: Evaluation of Adverse Events

Post-Marketing Safety of Tazemetostat in Antitumor Therapy: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System

Control administrativo en farmacovigilancia: logros y desafíos en el Instituto Nicaragüense de Seguridad Social, Nicaragua 2024.

“Trends and challenges in adverse drug reaction reporting in Spain: Analysis of the FEDRA database (2019–2023)”

Abuse liability of dextromethorphan and its combinatory formulation dextromethorphan/bupropion: a pharmacologic perspective

Hypersensibilité médicamenteuse chez les bovins. Récit du traitement d'un signal en pharmacovigilance vétérinaire

Assessing DDI risks in drug discovery and development: approaches, challenges, and trends

Drug-drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors

Ethiopia Launched National Strategy to Combat Substandard and Falsified Medical Products (2026–2030)

Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision Making

La AEMPS informa de la detección en el mercado europeo de unidades falsificadas de la prueba de autodiagnóstico COVID-19 and Influenza A+B Antigen Combo Rapid Test

OPS y ANMAT avanzan en la conformación de una red federal de farmacovigilancia en Argentina

Veterinary Drug Residues in Food Chains: Sources, Exposure Pathways, Health Impacts, Mitigation, and Safety Assurance

Research and practice on key drug safety monitoring under the normalization of centralized procurement: A case study of 13 selected drugs in a Province

A real-world pharmacovigilance study of FDA adverse event reporting system events for cefazolin

Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study

Drug toxicity deaths associated with opioid agonist treatment: An analysis of methadone and buprenorphine-related fatalities in Victoria, Australia

Hospitalization linked to antiepileptics, sedative-hypnotics and anti-Parkinsonian drug poisoning, adverse effects, and underdosing in Australia: An ecological study

ISP incorporará la terminología MedDRA al Sistema de Vigilancia Integrada (SVI) para el reporte de eventos adversos

Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance Database

Pattern, Severity, and Preventability of Adverse Drug Reactions in a Tertiary-Care Hospital: Insights from Central India

Nuevo método de tecnovigilancia para dispositivos de estimulación eléctrica transcorneal

Leveraging Large Language Models for Adverse Drug Event Detection: A Comparative Study of Token and Span-Based Named Entity Recognition

Adverse drug event signal detection and risk factor analysis of blinatumomab in ten years of post-marketing use

Chinese Herbal Medicine in Pediatric Oncology: Effects on Survival and Toxicity – A Meta-analysis

Nonfatal Drug Overdose in a National Sample of Adolescents by Intent and Substance, Medicaid 2016-2020

Trial-Based Costs for Interventions to Improve HPV Vaccine Uptake

High-Risk Penicillin Reaction Flags in the Medical Record

Contraceptive Tied to Higher Brain Tumor Risk in Women

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs

Medical Product Alert N°7/2025: Falsified IBRANCE (palbociclib)

Leveraging the Lanham Act for anti-counterfeiting: A case study of Gilead Sciences' successful civil-to-criminal enforcement strategy in the US pharmaceutical market

Blockchain and Artificial Intelligence in Pharmaceutical Supply Chain Traceability: A Systematic Review

Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance

The impact of artificial intelligence-driven decision support on uncertain antimicrobial prescribing: a randomised, multimethod study

WHO and the European Commission expand partnership to combat antimicrobial resistance

Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism

Precision pharmacovigilance integrates genomics and real world evidence to overcome drug safety barriers

Diseases are not treated with words, but with medicines. Setting up galenic laboratories in Africa

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the Clinical Practice Research Datalink (CPRD)

A Patient Needs a Drug. They Have Their Own Ideas. What Now?

Towards interprofessional medication safety risk management: a qualitative interview study for physicians in primary and secondary care

Exposing Vulnerabilities in Counterfeit Prevention Systems Utilizing Physically Unclonable Surface Features

Evaluating and Optimizing Machine Learning Models to Predict Drug Side Effects

Recent Advances on Thermochromic Inks for Security Applications

Disproportionality and time-to-onset analyses of drug-induced weight gain using the Japanese Adverse Drug Event Report database

Improving Pharmacovigilance via Systematic GASS Screening and Interdisciplinary Collaboration in the Outpatient Setting

Real world based on FAERS database: To explore the mining and analysis of adverse pregnancy events related to drug exposure

Comparative Real-World Safety Profiles of Six Selective Serotonin Reuptake Inhibitors: A Global Pharmacovigilance Analysis

Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025

Assessment of Pharmacovigilance Practices in Primary Healthcare Facilities in Nasarawa State, Nigeria

Enhancing Medication Safety with LLMs

Safety of Herbal Medicine in the Postpartum Period: A Hospital-Based Single-Arm, Prospective Observational Study (SAFEHERE-PC)

Role of Metabolites in Drug-Drug Interactions

Placebo in controlled clinical trials

Engagement and Awareness in the Age of Memes

Spain’s Rise in Off-Label Doxycycline Use for Sexually Transmitted Infections

ISMP Announces New Medication Safety Best Practices

A Single-Center Prospective Study on Adverse Drug Reactions Associated With Polypharmacy in Elderly Outpatients

A Survey of Knowledge, Attitude, and Practice of Reporting of Adverse Drug Reactions by Indian General Population

Artificial Intelligence-driven prediction of Drug–Herb Interactions: A critical need in India’s pluralistic health culture and Pharmacovigilance framework

Digital monitoring in the Ayush Pharmacovigilance for safer health care

A meta-contrastive learning approach for clinical drug-drug interaction extraction from biomedical literature

The promise of cardiomyocyte computational models for drug safety

Prescribed Drugs and Interpersonal Violence: A Case–Non-Case Study in the Spanish Pharmacovigilance Database

Large Language Models for Drug-Related Adverse Events in Oncology Pharmacy: Detection, Grading, and Actioning

Assessment of pharmacovigilance awareness and adverse drug reaction reporting among hospital pharmacists: A nationwide survey

Peligros de la desinformación relacionada con la cardiología en las redes sociales

Estudio del Hospital Clínico Universidad de Chile alerta por resistencia a fármacos contra el VIH

Commission presents new EU Drugs Strategy and Action Plan against drug trafficking to protect citizens and disrupt criminal networks

Antibiotic-induced adverse drug reactions: investigating the utility of routinely collected data

Detection and Management of Signals Associated with Adverse Drug Reactions from Atorvastatin and Rosuvastatin: An Observational Study

Comparative Safety Profiles of Spironolactone, Eplerenone, and Finerenone: A Pharmacovigilance Study Based on FAERS Data from 2004 to 2024

Selection of Local Journals for Medical Literature Monitoring in Poland for Pharmacovigilance. Standard of the Polish Society of Pharmacovigilance–replication study

Machine learning methods for predicting adverse drug events: A systematic review

Pharmacovigilance in the field of addiction: challenges and emerging solutions

Pharmacovigilance assessment of ropivacaine safety using FAERS data (2004–2024)

Peripheral Neuropathy Associated With Proteasome Inhibitors and Immunomodulatory Drugs: A Pharmacovigilance Disproportionality Analysis Using VigiBase

Real-World Evidence for Medicare Drug Price Negotiations

Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises

La industria farmacéutica valora el posicionamiento del Consejo de la UE sobre la Ley de Medicamentos Críticos

pvEBayes: An R Package for Empirical Bayes Methods in Pharmacovigilance

Las farmacias sevillanas contarán con un servicio especializado en seguridad de medicamentos

Safety considerations for patients using cannabis

A real-world safety analysis of infection-related adverse events associated with belimumab, rituximab, and TNF inhibitors using the FAERS database

Vaccinating in the Shoulder: Why Needle Length Matters

Prediction of Pregnancy-Related Adverse Drug Reactions from Chemical Conformers Using a Fractional-Pooling Dilated CNN

World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises

Patient and family experiences inform antidepressant safety information review

Striking the Balance: Evidence-Based versus Defensive Medicine

GLP-1 RAs: warnings aligned over potential risk of suicidal thoughts or behaviours

Prevalence, associated factors, and safety implications of prehospital herbal medicine use in Southwestern, Ethiopia

The role of community pharmacy professionals in combating Counterfeit and substandard drugs in the Amhara regional state, Ethiopia

COFEPRIS registra más de 77 mil reportes de vigilancia sanitaria en 2025

UNICEF alerta de que la brecha en el tratamiento del VIH pone en peligro a millones de niños

Quality Indicators for Drug Dispensing in Community Pharmacies: A Scoping Review Protocol

A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use

Enhancing Patient Education on Safe Crushing of Hazardous Oral Medications for Patients With Swallowing Difficulties at Home

Drug-induced immune-mediated uveitis: a real-world pharmacovigilance analysis using FAERS and JADER databases

Adverse Drug Reactions and Drug Interactions in Multimorbid Patients: A Review of Current Evidence

A Hybrid System for Comprehensive and Consistent Automated MedDRA Coding of Adverse Drug Events

Don't License AI to Prescribe Medication — A bill in Congress confuses device clearance with medical judgment

Could dedicated pharmacists help improve neonatal care’s medicines safety problem?

A popular “essential” medicine may be putting unborn babies at risk

Indecopi informa sobre nuevos riesgos en el uso del fentanilo alertados por la Digemid

Global epidemiology of vaccine-associated intussusception in children and adolescents, 1968 to 2024: An international pharmacovigilance study

Are Sexual Side Effects Emerging With GLP-1 Agonists?

Strengthening Signal Detection in Pharmacovigilance by Using International Nonproprietary Name (INN) Stems

Safety evaluation of selective estrogen receptor degraders (SERDs) using real-world evidence from the FDA Adverse Event Reporting System (FAERS)

Adverse Effects of Posaconazole on Adrenal Steroid Biosynthesis: An Integrative Approach Using FAERS-Based Pharmacovigilance and Systematic Review with Meta-Analysis of Randomised Controlled Trials

Sedative-hypnotic drug use and risk of falls and fractures in elderly patients: a cross-sectional study

Three Found Guilty Over Illegal Medicines Network

Sociodemographic and geographical variation in prescribing psychotropic drugs to children and young people with common mental disorders and Attention Deficit Hyperactive Disorders in North West London: population-based study

Poor-Man’s Polypill Promising in HF: POLY-HF Discussed

Trimethoprim-Sulfamethoxazole and Acute Respiratory Failure in Adolescents and Young Adults

Maternal Use of Integrase Strand Transfer Inhibitors During Pregnancy and Infant Neurodevelopment

La V edición de “¡Corre sin resistencias!” reúne en 2025 a cerca de 5.000 participantes para promover el uso prudente de los antibióticos

Brand protection and counterfeit products: An examination of resourcing

Visited India? Metronidazole may not cure your Giardia infection

The post-marketing safety of Esketamine among older adults(≥ 65): an real-world pharmacovigilance study

Pharmacovigilance Insights into Ibuprofen's Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity

Bridging pharmacovigilance and genetic insight: investigating drugs and indications for breast cancer risk in women with autoimmune diseases

EcoDrug PLUS: an advanced database for drug target conservation analysis and environmental risk assessment

A Prospective Study on Adverse Drug Reactions Caused by Chemotherapy in Cancer Patients

Computational Pharmacovigilance Analysis of Longevity-Relevant Drugs: A Multi-Method Signal Detection Study Using FAERS Data

Drugs induced Raynaud's phenomenon and underlying mechanism: a disproportionality analysis from the WHO pharmacovigilance database

CFTR during pregnancy and adverse drug reactions: A pharmacovigilance disproportionality analysis in VigiBase

Harmonizing health: a global analysis of pharmaceutical regulatory activities by international regulatory organizations

Adverse Drug Reactions in Polypharmacy: A Real-World Pharmacovigilance Study Using EHR Data

Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database

Docs Must Share Correct Info About Tylenol and Autism, Ethicist Says

Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Major Bleeding With Apixaban vs Aspirin. A Subanalysis of the ARTESiA Randomized Clinical Trial

Updated Labeling for Menopausal Hormone Therapy

Why Doctors Hesitate to Say ‘I'm Sorry’ After Errors

Patient-Reported Skin Changes After GLP-1 Use Explored

Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer

WHO Warns of Surging Levels of Antibiotic Resistance

Perspectives on Managing Antibiotic Resistance

Common Painkillers May Accelerate Antibiotic Resistance, Study Warns

El PRAN celebra la jornada “Desmontando bulos, frenando resistencias” para promover el uso prudente de los antibióticos

La AEMPS refuerza la cooperación regulatoria en América Latina y el Caribe para avanzar hacia la autosuficiencia sanitaria

Boletín sobre Seguridad de Medicamentos de Uso Humano. Agosto y septiembre de 2025

FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies

Madrid suma 23 nuevas oficinas de farmacia a su red centinela para detectar problemas de seguridad con medicamentos

Retiran más de 140.000 frascos de un popular medicamento contra el colesterol alto

A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System

Inhaler-Related Greenhouse Gas Emissions in the US. A Serial Cross-Sectional Analysis

GLP-1 Agonists Linked to Anorgasmia in a 71-Year-Old Woman

Incorporating Social Determinants of Health Into Clinical Practice Is Central to Improving Care and Outcomes

Real-World Evidence in Drug Approvals at the European Medicines Agency

Common OTC Sleep Aid Linked to Heart Failure Risk

The Off-Label Treatment That Helps Many With Fibromyalgia

Cannabis for Rheumatic Pain? Experts Call for More Evidence

Which Contraceptives Tied to Greater Breast Cancer Risk?

La AEMPS participará de nuevo en la #MedSafetyWeek, que celebra su décimo aniversario con el fin de promover la notificación de sospechas de reacciones adversas de medicamentos

Before, With, or After Meals? Why Pill Timing Matters

Cardiometabolic Effects of Antidepressants Vary Significantly

Opioid Abuse

Time to Reconsider Tramadol for Chronic Pain?

Systemic Drugs Associated With Maculopathy

Alternatives to Government-Imposed Price Controls to Lower US Drug Prices

Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab

One in 6 Common Bacterial Infections Are Resistant to Antibiotics, WHO Warns

Principales enfermedades pediátricas con implicación farmacológica

Fatal Mix-Ups Spur EMA Warning on Tranexamic Acid Use

Serena Williams Sparks Debate Over GLP-1 Promotion

Nitrous Oxide Deaths: A Growing US Health Crisis?

EMA: Deworming Med Under Review for Brain Side Effects

La EMA y HMA advierten del aumento de medicamentos ilegales comercializados como análogos de GLP-1

Priorities for a New FDA

Evaluating pharmacist prescribing education programmes: a realist synthesis protocol

Creating an evidence map of the safety profile of spironolactone across all clinical indications to establish whether it may be a safe treatment in female adolescent acne: a protocol for a scoping review

A crisis of credibility: the global cost of US vaccine misinformation

Managing Adverse Effects of Obesity Medications

Threats of Weather Disasters for Drug Manufacturing Facilities in the US

Consentimiento informado: ¿qué tanto recuerda el paciente de tu explicación?

Vitamin D Overdose: When Good Intentions Turn Toxic

Alerta sobre los riesgos del consumo irracional y sin control médico de vitamina D

Common Painkiller Tied to Heart Failure Risk in Older Adults

Recomendaciones para un mejor uso de los psicofármacos

Clinical Trials May Not Differentiate, but Data Show Women More Likely to Report Issues With GLP-1s

EMA Decision Is In: Finasteride Linked to Suicidal Ideation

La AEMPS lanza MeQA, una herramienta de IA pionera en la respuesta a preguntas sobre medicamentos de uso humano

Deprescribing in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis

Safety of Stimulants Across Patient Populations. A Meta-Analysis

Effectiveness and Safety of Respiratory Syncytial Virus Vaccine for US Adults Aged 60 Years or Older

How can community pharmacy teams prevent prescription and over-the-counter opioid misuse in North East England? A qualitative study using the Capability, Opportunity and Motivation Behaviour (COM-B) model

The Positive Pharmacy Care Law revisited: an area-level analysis of the relationship between community pharmacy distribution, urbanicity and deprivation in England

Side Effect Fears Deter European Teens From Vaccines

Medication Overuse Headache: A Headache Expert’s Tips

En un estudio se relaciona la obesidad con la ineficacia de biofármacos en la psoriasis

Oral, Injected Semaglutide May Pose Distinct Eye Risks

Vaccinations Show No Link to Risk for Rheumatoid Arthritis

Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years. A Randomized Clinical Trial

Racial and Ethnic Disparities in Receipt of ERBB2-Targeted Therapy for Breast Cancer, 2010-2020

Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US

‘Off-Label’ Dosing to Personalize GLP-1 Doses

Vaccination Slumps and Research Cuts Threaten Long-Term Public Health

Switching to Three-Drug Regimen Efficacious in People With Suppressed HIV and Preexisting Resistance

Minnesota Bill Against Vaccines Promotes Disinformation

Childhood Antibiotic Use Linked to Increased Risk for Asthma, Food Allergies, and Intellectual Disability

Hyperglycemia: A Risky Side Effect of Certain Cancer Drugs

Unreliable Vaccine Information and the Erosion of Science

Why a Placebo May Work Better When You Know It’s a Placebo

WHO ‘Wake-up Call’: Measles in Europe Highest in 25 Years

Racial Bias in Antipsychotic Prescribing: A Call for Equity

Antibiotics During Infancy Induce Microbiome Changes, Raise Risk for Childhood Asthma by 30 Percent

"Reto del Paracetamol": cuidado con las intoxicaciones deliberadas en niños y adolescentes

Antidepressant Therapy Linked to a 2% Weight Gain

Antidepressants Linked to Sudden Cardiac Death Risk, Early Results Suggest

Benefits Outweigh Risks for Weight Loss Drug Mysimba

Laboratorio Medifarma se pronuncia tras muertes por suero fisiológico y responde a clínica Sanna

Two New Studies Add to Evidence Cannabis Harms Cardiovascular System

Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA

Older Adults’ Views on Insurance Coverage for Weight Management Medications

Quantitative Bias Analysis for Single-Arm Trials With External Control Arms

Sarepta Says Teen Died After Its Gene Therapy Treatment

‘Paracetamol Challenge’ Risks Fatal Consequences for Teens

Preservative-Free Glaucoma Drops Improve IOP and Eye Health

AI ‘Hallucinations’ Are Changing Medicine — Should We Worry?

Prescription Stimulant Misuse Alarmingly Common

Seven vs Fourteen Days of Antibiotics for Gram-Negative Bloodstream Infection. A Systematic Review and Noninferiority Meta-Analysis

Manual vs AI-Assisted Prescreening for Trial Eligibility Using Large Language Models—A Randomized Clinical Trial

Defining the need for analgesia in the emergency department: protocol for an international Delphi process

Safety and effectiveness of multimodal opioid-free anaesthesia for pain and recovery after laparoscopic surgery: a systematic review and meta-analysis

Physicians Welcome Testosterone Labeling Changes

GPT for RCTs? Using AI to determine adherence to clinical trial reporting guidelines

Lessons learnt from daily oral PrEP delivery to inform national planning for PrEP ring introduction for women in low-income and middle-income countries: a qualitative inquiry of international stakeholders

Policy uptake and implementation of the RTS,S/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation

‘Being disabled’ as an exclusion criterion for clinical trials: a scoping review

El uso de corticoides a dosis altas en los pacientes con lupus se relaciona con complicaciones de salud

Drug Versioning and Legal Accountability for Preventable Product Harms

Regulation of Health and Health Care Artificial Intelligence

AI ‘Hallucinations’ Are Changing Medicine — Should We Worry?

La EMA y HMA publican la estrategia conjunta de la red regulatoria europea hasta 2028

The Bad Medicine of Doctored

Do We Know Enough About Assisted Dying Drugs?

Cannabis Is Interfering With the Heart

Boletín sobre Seguridad de Medicamentos de Uso Humano. Enero de 2025

A 'Concerning' Trend: Cosmetics Retailers Targeting Tweens and Preadolescents

The Other Vaccine-Preventable Diseases Worrying Doctors Now

Transdermal Beats Oral Estrogen for CVD Safety of Hormone Therapy

Artificial intelligence in public health: promises, challenges, and an agenda for policy makers and public health institutions

Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries

This Bill Could Make It Legal for AI to Prescribe Medicine

FDA Ended Clozapine REMS. But Will It Increase Prescribing?

NHL: Are Bispecific Antibodies a Safe Treatment?

Drug Labels Often Neglect to Inform About Obesity Dosing

Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021

Claves para no convertirte en una fábrica de superbacterias

Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide

Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes. A Network Meta-Analysis

Not All Children Respond to Vaccinations the Same

Altas tasas de lesión hepática inducida por avacopán en vasculitis

Warning of Confusion Between Nasal and IV Epinephrine

Vitamin D? ‘Save Your Money’

New Data Shed Light on Who Stops Using GLP-1 Drugs, and Why

How to Reduce Nocebo Concerns in Biosimilar Use

Patients Are Flocking to Compounded Weight-Loss Drugs, but Are They Safe?